OvaGene Lab Receives CLIA Certification | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics firm OvaGene on Monday announced its laboratory has received Clinical Laboratory Improvement Act certification, making it fully licensed to receive patient clinical specimens from gynecological oncologists from most of the US.

Based in Irvine, Calif., OvaGene develops gene-based diagnostics for gynecological cancer.

Frank Kiesner, chairman and CEO of OvaGene, said the certification marked a milestone for the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.